SistemPSCCheck™ is a first-in-class miRNA-based assay, for high sensitivity assessment of residual undifferentiated PSCs in derived cell preparations. SistemPSCCheck™ is a safety and batch release assay service to support the clinical and commercial development of pluripotent stem cell-derived cell therapy products.
SistemPSCCheck™ was developed in conjunction with National Measurement Laboratory for Chemical and Bio-Measurement at LGC and was supported by the UK’s innovation agency, Innovate UK, under the “Analysis for Innovators” grant.
To see the full featured case study on the Analysis for Innovators website, please visit:
To see the full featured case study on LGC’s website, please visit:
https://www.lgcgroup.com/our-impact/ and look under the “Case studies supporting healthcare” section